DIRECT TARGETING OF THE FKBP52 COCHAPERONE FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER

$491,132FY2017Department of the ArmyDOD

The University Of British Columbia

Investigators